AQR Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,270
Closed -$526K 2528
2023
Q4
$526K Sell
22,270
-9,839
-31% -$175K ﹤0.01% 1859
2023
Q3
$479K Sell
32,109
-8,378
-21% -$111K ﹤0.01% 1861
2023
Q2
$443K Buy
+40,487
New +$377K ﹤0.01% 1826
2021
Q4
Sell
-10,578
Closed -$39K 2310
2021
Q3
$39K Buy
+10,578
New +$41.7K ﹤0.01% 2229
2021
Q1
Sell
-90,221
Closed -$518K 2285
2020
Q4
$518K Buy
+90,221
New +$683K ﹤0.01% 1764
2020
Q1
Sell
-18,335
Closed -$36K 2182
2019
Q4
$36K Buy
+18,335
New +$68.9K ﹤0.01% 2104
2019
Q1
Sell
-21,993
Closed -$173K 2237
2018
Q4
$173K Sell
21,993
-18,603
-46% -$177K ﹤0.01% 2101
2018
Q3
$450K Buy
40,596
+7
+0% +$87 ﹤0.01% 1986
2018
Q2
$545K Buy
+40,589
New +$508K ﹤0.01% 1951

Other funds holding CBAY